Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Iran Presents New Anti-Cancer Nanodrug to Market

Abstract:
Iran presented to the market on Wednesday a new home-made nanodrug for chemotherapy, giving cancer patients a new hope.

Iran Presents New Anti-Cancer Nanodrug to Market

Tehran, Iran | Posted on June 16th, 2012

"The first home-made chemotherapy drug produced by utilizing nanotechnology was presented to the drug market today and can be used by gastrointestinal cancer patients," Iranian Deputy Health Minister for Food and Drugs Affairs Ebrahim Sheibani told reporters on Wednesday.

He said that after the domestic production of the nanodrug, Iran's imports of chemotherapy medicines have decreased by $5mln.

Noting that Iran is now producing 97% of its drug needs, Sheibani said that despite the western sanctions against Tehran, the country is not faced with any crisis in providing chemotherapy medicine for the patients.

Iran has made huge achievements in various fields of science and technology, from nuclear knowledge to stem cell and Nano technology.

In a most recent case, Iranian Health Minister Marziyeh Vahid Dastjerdi announced in September that the country would soon start production of 15 types of anti-cancer drugs.

"15 types of monoclonal anti-body drugs are being synthesized with the help of the Scientific Department of the Presidential Office, using hi-tech technology," Vahid Dastjerdi said.

Also earlier this year, Iranian scientists succeeded in producing new types of medication for treating different kinds of cancer, viral diseases and arthritis with 100% positive results.

Sheibani had also earlier this year announced that the Iranian scientists managed to break Israel's monopoly by producing a new MS drug which makes Iranian patients needless of foreign medicines.

"Fortunately, the production monopoly on the drug was broken by Iran's pharmaceutical industries and is now being distributed in our country's drug market," he told reporters in March.

He also reiterated that the drug can be used even during pregnancy by ready-made injection syringe technology.

Also, Iran shattered the United States' monopoly in the production of the most important drugs in the treatment of MS in 2007.

Interferon beta 1, generically known as Ziferon, is mainly injected subcutaneously and has antiviral and immunomodulating properties. The drug is mainly used in the management of multiple sclerosis, although its mode of action is unclear.

####

For more information, please click here

Copyright © Fars News Agency

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Shape matters when light meets atom: Mapping the interaction of a single atom with a single photon may inform design of quantum devices December 4th, 2016

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Novel Electrode Structure Provides New Promise for Lithium-Sulfur Batteries December 3rd, 2016

Research Study: MetaSOLTM Shatters Solar Panel Efficiency Forecasts with Innovative New Coating: Coating Provides 1.2 Percent Absolute Enhancement to Triple Junction Solar Cells December 2nd, 2016

Nanomedicine

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Nanobiotix Provides Update on Global Development of Lead Product NBTXR3: Seven clinical trials across the world: More than 2/3 of STS patients recruited in the “act.in.sarc” Phase II/III trial: Phase I/II prostate cancer trial now recruiting in the U.S. November 28th, 2016

From champagne bubbles, dance parties and disease to new nanomaterials: Understanding nucleation of protein filaments might help with Alzheimer's Disease and type 2 Diabetes November 24th, 2016

Nanopolymer-modified protein array can pinpoint hard-to-find cancer biomarker November 17th, 2016

Discoveries

Shape matters when light meets atom: Mapping the interaction of a single atom with a single photon may inform design of quantum devices December 4th, 2016

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Novel Electrode Structure Provides New Promise for Lithium-Sulfur Batteries December 3rd, 2016

Research Study: MetaSOLTM Shatters Solar Panel Efficiency Forecasts with Innovative New Coating: Coating Provides 1.2 Percent Absolute Enhancement to Triple Junction Solar Cells December 2nd, 2016

Announcements

Shape matters when light meets atom: Mapping the interaction of a single atom with a single photon may inform design of quantum devices December 4th, 2016

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Novel Electrode Structure Provides New Promise for Lithium-Sulfur Batteries December 3rd, 2016

Research Study: MetaSOLTM Shatters Solar Panel Efficiency Forecasts with Innovative New Coating: Coating Provides 1.2 Percent Absolute Enhancement to Triple Junction Solar Cells December 2nd, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project